Financial Year |
March 31 2023 |
Monetary Funds |
2,762,201,767.02 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
343,058,912.31 |
Accounts Receivable |
10,050,018,255.14 |
Advances to Suppliers |
3,788,411,733.42 |
Other Receivables |
1,997,652,864.56 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
1,048,924.55 |
Dividend Receivable |
-- |
Inventories |
5,560,756,627.07 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
37,673,670.99 |
Other Current Assets |
377,802,483.72 |
Total Current Assets |
25,308,816,814.81 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
85,585,780.61 |
Long-term Equity Investment |
191,857,259.85 |
Investment Properties |
170,181,617.16 |
Fixed Assetes |
901,786,574.36 |
Under-construction Projects |
99,437,289.09 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
552,610,469.86 |
R&D expenses |
-- |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
26,623,954.68 |
Deferred Income Tax Assets |
644,270,830.58 |
Other Non-Current Assets |
5,000,000.00 |
Sub-Total of Non-Current Assets |
3,086,813,317.03 |
Total Assets |
28,395,630,131.84 |
Short-Term Loans |
4,453,492,427.93 |
Trading Financial liabilities |
-- |
Notes Payable |
5,371,280,720.05 |
Accounts Payable |
2,778,242,428.93 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
210,684,678.72 |
Taxes Payable |
155,700,328.08 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
3,430,626,730.58 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
577,263,805.76 |
Other Current Liabilities |
558,826,156.06 |
Sub-Total of Current Liabilities |
20,509,357,534.45 |
Long-term Loans |
1,345,500,000.00 |
Bonds Payable |
-- |
Long-Term Accounts Payable |
18,116,886.66 |
Special Payable |
-- |
Estimatied Liabilities |
375,458,715.70 |
Deferred Income Tax Liabilities |
51,333,961.67 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
1,876,227,906.06 |
Total Liabilities |
22,385,585,440.51 |
Paid-In Capital(Or Share Stock) |
1,071,910,711.00 |
Capital Surplus |
4,191,020,369.95 |
Surplus Reserve |
969,212,486.45 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
-1,384,641,300.04 |
Minority Stockholder's Interest |
165,718,802.78 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,844,325,888.55 |
Owner's Equity(Stockholder's Equity) |
6,010,044,691.33 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
28,395,630,131.84 |